Mark Hahn - May 3, 2022 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role: Chief Financial Officer
Signature: /s/ Claire Poll, Attorney-in-fact for Mark Hahn
Stock symbol: VRNA
Transactions as of: May 3, 2022
Transactions value $: -$6,201
Form type: 4
Date filed: 5/5/2022, 07:18 PM
Previous filing: May 3, 2022
Next filing: Aug 3, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VRNA	Ordinary Shares	Sale	-$6.2K	-12.5K	-0.08%	$0.50^*	15.4M	May 3, 2022	Direct	F1, F2, F3, F4

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2	The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
F3	The price reported represents the sale price of the ADSs divided by eight (8).
F4	Consists of (i) 8,191,744 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,023,968 ADSs); and (ii) 7,189,776 Ordinary Shares underlying 898,722 ADSs.